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AbsTRACT 
Objective To determine whether reported therapeutic 
interventions for arthrogenic muscle inhibition (AMI) in 
patients with ACL injuries, following ACL reconstruction, 
or in laboratory studies of AMI, are effective in improving 
quadriceps activation failure when compared with 
standard therapy in control groups.
Design A scoping review of the efficacy of interventions 
was conducted in accordance with the methodological 
framework of Arksey and O’Malley and the Preferred 
Reporting Items for Systematic Reviews and Meta-
Analyses guidelines. Search terms included ’arthrogenic 
muscle inhibition’, ’quadriceps activation following 
knee injuries’, ’anterior cruciate’ or ’knee’ combined 
with ’quadriceps activation’, ’quadriceps inhibition’, 
’corticomotor’, ’arthrogenic’, ’brain activation’ and 
’neuroplasticity’. Articles were evaluated for risk 
of bias using the PEDro (Physiotherapy Evidence 
Database) criteria. The overall quality of evidence 
for each intervention was assessed using Grading of 
Recommendations Assessment, Development and 
Evaluation (GRADE).
Data sources PubMed, EMBASE and Cumulative Index 
to Nursing and Allied Health Literature databases.
Eligibility criteria for selecting studies Isolated 
case reports and articles reporting outcomes in patients 
with chronic disease or major trauma were excluded. All 
other original research articles were included.
Results 780 potential articles were identified. 20 met 
the inclusion criteria. These studies provided a moderate 
quality of evidence to support the efficacy of cryotherapy 
and physical exercises in the management of AMI. There 
was low-quality evidence for efficacy of neuromuscular 
electrical stimulation and transcutaneous electrical nerve 
stimulation, and very low-quality evidence for efficacy of 
ultrasound and vibration.
Conclusions This scoping review demonstrated 
moderate-quality evidence for the efficacy of cryotherapy 
and physical exercises in improving quadriceps activation 
failure after ACL injury and reconstruction. These 
therapeutic modalities are therefore recommended in the 
management of AMI.
InTRODuCTIOn
Quadriceps weakness is a frequently observed 
barrier to effective rehabilitation following ACL 
injury and reconstruction.1 2 It may lead to a 
wide range of important consequences, including 
extension deficit,3 gait abnormality,4 quadriceps 
atrophy,1 5 6 poor function,6 dynamic instability,7 
persistent knee pain and early osteoarthritis.1 8 
Quadriceps activation failure after ACL recon-
struction (ACLR) is not simply an isolated local 
phenomenon related to atrophy. Many authors 
describe its synchronous occurrence in both recon-
structed and contralateral limbs.9 This has been 
attributed to arthrogenic muscle inhibition (AMI), 
a process in which quadriceps activation failure is 
caused by neural inhibition. Mechanisms for this 
inhibition include alteration in muscle resting motor 
thresholds, changes in the discharge of articular 
sensory receptors, altered spinal reflex excitability 
(affecting the group I non-reciprocal (Ib) inhibitory 
pathway, the flexion reflex and the gamma loop)10 
and abnormal cortical activity (intracortical inhibi-
tion and a requirement for greater frontal cortex 
theta power in basic movement and joint position 
sense tasks).11 12
Recently, several clinical studies have suggested 
specific treatment modalities for AMI.13–34 Most 
of the therapeutic interventions for AMI aim to 
alter motor excitability using disinhibitory mech-
anisms.35 These improve voluntary quadriceps 
activation by targeting either joint mechanore-
ceptors, the peripheral nervous system around the 
joint (mainly group III and IV afferent nerves) or 
the central nervous system directly.10 35 The aim of 
this scoping review was to determine the strength 
of evidence supporting the use of common thera-
peutic interventions for AMI in patients with ACL 
injuries, following ACLR, or in laboratory studies 
of AMI.
METhODs
We conducted a scoping review as this approach 
is superior to a systematic review in addressing an 
exploratory research question.36 37 We followed the 
five-stage methodological framework of Arksey and 
O’Malley36 and the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses 2009 check-
list (see figure 1). The study protocol was regis-
tered with PROSPERO (International prospective 
register of systematic reviews) database (trial regis-
tration number: CRD42017067499).
stage 1: identifying the research question
Our research question was ‘What is the strength of 
evidence supporting the use of common therapeutic 
interventions for AMI in patients with ACL inju-
ries, following ACL reconstruction, or in laboratory 
studies of AMI?’
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stage 2: identifying relevant studies
The literature search used subject mapping and keywords and 
is presented in online supplementary appendix 1. The search 
strategy was applied to the PubMed, EMBASE and Cumulative 
Index to Nursing and Allied Health Literature databases by two 
authors independently on 12 March 2017. The same authors 
also independently performed all aspects of the study selection.
stage 3: study selection
We included primary research studies that evaluated the efficacy 
of therapeutic interventions for AMI. The main focus of the 
review was on AMI in patients following ACL injury or recon-
struction. Due to the fact that treatment of AMI is an emerging 
concept with a small evidence base, it was deemed appropriate 
to use a scoping review methodology and include studies that 
intended to evaluate the efficacy of therapeutic interventions 
for the same pathological processes in selected, relevant, alter-
native settings. Therefore, studies including young patients with 
artificially induced knee effusions and other relevant acute knee 
pathologies (restricted to other knee ligament injuries, meniscal 
pathology and patellofemoral instability) were also included. 
Only studies published in the English language were included.38 39
We excluded isolated case reports and articles which included 
patients with chronic conditions (eg, osteoarthritis) or major 
trauma (fracture, multiligament injury, neurovascular injury). 
Any disagreement between reviewers regarding study eligibility 
were resolved through discussion.
Each article was reviewed for relevance, and the references of 
the included articles were examined to identify further eligible 
studies.
stage 4: charting the data
Data extraction and risk of bias assessment were performed 
independently by two investigators. A template was used for 
data extraction that included study design, participants, inclu-
sion/exclusion criteria, intervention investigated, compar-
ators, outcome measures (quadriceps activation/strength 
including central activation ratio (CAR), peak torque, 
maximal voluntary isometric contraction (MVIC), H-reflex 
amplitude, knee flexion angle symmetry and muscle fibre 
conduction velocity), main findings, conclusion and level of 
evidence.
stage 5: collating, summarising and reporting the results
Due to heterogeneity among studies with respect to the popu-
lations, interventions and outcomes studied, it was not possible 
to pool data. Instead, we collated efficacy data with respect to 
the outcome measures defined in stage 4 and synthesised a 
narrative summary of the evidence for each intervention.
To determine the strength of evidence, the following steps 
were undertaken. All included articles were individually evalu-
ated for risk of bias using the Physiotherapy Evidence Database 
(PEDro) criteria.40 41 The level of evidence for individual studies 
was assessed according to the Oxford Centre for Evidence-based 
Medicine.42 The overall quality of evidence for each therapeutic 
intervention was assessed using the GRADE working group 
grades of evidence.43 Details of how the GRADE guidelines were 
applied are included in online supplementary appendix 2. Effect 
sizes were calculated using the methodology of Thalheimer and 
Cook.44
Figure 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram.
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REsulTs
The search strategy yielded 780 articles. The references of these 
articles were then reviewed and a further six eligible studies were 
included. Five studies were removed as they were duplicates. 
After application of eligibility criteria, a total of 20 relevant 
articles were identified. The date of publication of the included 
studies ranged from 1990 to 2017.
Table 1 summarises the study characteristics, level of evidence 
of the included studies, outcomes, effect sizes and the GRADE 
recommendation for each intervention. Table 2 demonstrates 
how the PEDro scores were calculated for each study. Table 3 
demonstrates how the GRADE recommendations for each inter-
vention were determined. The mechanism and level of action of 
the therapeutic interventions studied are summarised in figure 2.
Cryotherapy
Four studies evaluated the efficacy of cryotherapy in AMI. This 
included three randomised controlled trials (RCTs). All studies 
showed that cryotherapy improved the features of AMI; effect 
sizes were very large. Specifically, three of the studies demon-
strated that cryotherapy was associated with significant improve-
ment in quadriceps strength (measured by maximal voluntary 
isometric contraction).14–16 Additionally, Hopkins et al13 demon-
strated a significant improvement in quadriceps motor neuron 
pool recruitment (measured by the H-reflex). Note that two 
of these studies did not specifically evaluate patients following 
ACLR—they were laboratory studies of patients with artificially 
created knee effusions.13 14
Using the GRADE approach, there was moderate-quality 
evidence for the efficacy of cryotherapy in the treatment of AMI.
Exercise
Four studies evaluating the efficacy of exercise therapy in 
patients with AMI after ACLR were identified. These included 
the cryotherapy-based studies from Hart et al and Kuenze et 
al,15 16 which also made an adjunctive use of exercise. All of the 
included studies demonstrated that exercise therapy was asso-
ciated with a significant improvement in quadriceps activation 
(MVIC and CAR).15–17 26
Three of the exercise programmes consisted of traditional 
open chain exercises with resistance, and progressive closed 
chain strengthening exercises of quadriceps and hamstring 
muscles.15–17 Resistance exercises included quadriceps sets, 
straight leg raises with hip abduction/adduction and progression 
to free-standing quarter squats, wall squats, hamstring curls, 
hip flexion/extension and leg press. Flexibility was attained 
using hamstring, quadriceps and calf stretching exercises. The 
fourth study examined the effect of a hamstring fatigue exer-
cise protocol on patients with AMI following ACLR, in a case–
control study.26 Hamstring fatigue was induced by participants 
performing squats to a height of approximately 0.45 m from 
the ground at the rate of one squat every 2 s. The quadriceps 
CAR of the ACLR group was significantly higher when evaluated 
after hamstring fatigue exercises (mean 96.0%, SD 7.6%) versus 
prefatigue (mean 81.2%, SD 15.8%; p=0.01).
GRADE assessment revealed moderate-quality evidence for 
the efficacy of exercise in the treatment of AMI.
neuromuscular electrical stimulation
Two studies evaluated the same cohort of non-randomised 
patients who were allocated to four different rehabilitation 
groups.17 18 The authors reported that the group with combined 
neuromuscular electrical stimulation (NMES) and eccentric 
exercise demonstrated restored biomechanical limb symmetry 
that most closely resembled a control group of healthy individ-
uals.18 However, there was no advantage with respect to quad-
riceps strength and activation.17 Furthermore, eccentric exercise 
alone recovered quadriceps strength (MVIC) better than indi-
viduals who only received NMES therapy, or the standard care 
following ACLR.17
Patterned electrical neuromuscular stimulation is a form of 
NMES which is proposed to mimic muscle-firing patterns of 
healthy individuals. A randomised trial failed to demonstrate 
any difference in knee extension torque or quadriceps activa-
tion, compared with a sham treatment.27
GRADE assessment revealed low-quality evidence for the effi-
cacy of NMES in the treatment of AMI.
Transcutaneous electrical nerve stimulation
In the only randomised clinical study of transcutaneous electrical 
nerve stimulation (TENS) in patients with ACL rupture, there 
was no difference in isometric strength and quadriceps CAR 
among three groups (exercise only, exercise and TENS device, 
and 20 min of cryotherapy immediately prior to each daily 
exercise session).21 While all groups demonstrated a significant 
improvement in quadriceps strength, and effect sizes suggested 
potential clinical benefit to patients with AMI, the disinhibitory 
modalities were no better than exercise alone.
Three randomised trials, however, have shown some effect of 
TENS in improving AMI in the laboratory setting.13 19 20 Two 
trials showed a significant improvement compared with controls 
in the quadriceps muscle strength (MVIC),19 20 and the third 
showed it effectively disinhibited the quadriceps motor neuron 
pool (measured by H-reflex).13 Although TENS disinhibited the 
quadriceps motor neuron pool during the treatment, its bene-
ficial effects were lost 30 min after cessation of treatment. In 
contrast, the beneficial effects of cryotherapy continued up to 
the final measurement of the H-reflex at 60 min post-treatment.
GRADE assessment revealed low-quality evidence for the effi-
cacy of TENS in the treatment of AMI.
Vibration
Pamukoff et al22 evaluated the role of vibration therapy. The 
authors randomised ACL reconstructed patients to three groups 
(whole body vibration (WBV), local muscle vibration (LMV) 
and control). There was a statistically significant increase in 
CAR (+4.9%) following WBV and LMV (+2.7%). There was 
also a reduction in quadriceps active motor threshold following 
WBV (−3.1%) and LMV (−2.9%), suggesting that the interven-
tions increase corticomotor excitability. In a laboratory study, 
Blackburn et al23 also identified that quadriceps CAR improved 
in WBV (11.4%) and LMV (7.3%) groups, but not in controls. 
However, we contend that these small changes are of limited 
clinical significance, particularly given that the mean time since 
ACLR was over 50 months and the patients did not have proof of 
AMI. Furthermore, these studies only evaluated the immediate 
effects of WBV and LMV.
GRADE assessment revealed very low-quality evidence for the 
efficacy of vibration in the treatment of AMI.
ultrasound
An RCT evaluated patients with an intra-articular knee 
injury (22 of 30 were ACL injuries) and quadriceps 
CAR<90%.24 Non-thermal ultrasound (active) or sham treat-
ment was applied to the knee for a duration of 17 min. The 
investigators observed increased quadriceps motor neuron pool 
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excitability after ultrasound application compared with the sham 
group (14%–19% increase in the H-reflex amplitude, p=0.015).
GRADE assessment revealed very low-quality evidence for the 
efficacy of ultrasound in the treatment of AMI.
Transcranial magnetic stimulation
Only one trial was identified: an RCT (n=20) evaluated transcra-
nial magnetic stimulation (TMS) in patients who had a partial 
meniscectomy and ongoing quadriceps weakness (CAR<85%).28 
No significant difference in CAR or MVIC was seen compared 
with the control group that had no treatment. This systematic 
review did not identify any evidence supporting the use of TMS 
in the treatment of AMI.
Taping and bracing
Two RCTs assessed the effects of taping on quadriceps muscle 
performance.29 30 One assessed patients following ACLR,30 and 
the other assessed patients with a history of knee pathology and 
quadriceps CAR<90%.29 Neither study demonstrated a benefit 
over placebo for any outcome measure. A trial of 14 patients 
following ACLR randomised patients to receive either a knee 
brace, neoprene sleeve or no brace.31 No differences were 
observed between brace and no-brace conditions after aerobic 
exercise.
The available evidence does not support taping or bracing in 
AMI.
Other
A small case series of nine patients with anterior knee pain eval-
uated active release technique protocols.32 The active release 
technique is a system of soft tissue manipulation, purported 
to relieve tissue tension via the removal of fibrosis and adhe-
sions. There was no effect in reducing quadriceps inhibition or 
increasing quadriceps strength. Another study found application 
of local anaesthetic cream had no effect in improving the senso-
rimotor function of the knee in subjects with ACL injury.33 An 
RCT of 12 patients with a history of knee-joint pathology and 
quadriceps CAR of <90% evaluated superficial heat application 
and found no effect on quadriceps function.34
The available evidence does not support these treatments in 
AMI.
DIsCussIOn
AMI is responsible for a considerable morbidity after ACLR.1 3 5–8 
The main findings of this systematic review are that there is 
moderate-quality evidence to support the efficacy of cryotherapy 
and physical exercise therapy (open and closed chain resistance 
training, with hamstring fatigue exercises) in patients with AMI 
after ACL injury or reconstruction.
It is important to understand the pathophysiology of AMI 
to appropriately target therapeutic interventions. Several 
studies report an association between hamstring overactivity 
and dyskinesia with quadriceps weakness in AMI.45–47 This 
has been attributed to the flexion reflex spinal pathway, 
which produces a pattern of flexor facilitation and extensor 
inhibition. It is reported that greater hamstring coactiva-
tion is associated with significantly worse knee function.48 
It is therefore unsurprising that hamstring fatigue exercises 
in patients with AMI following ACLR have been reported 
to be associated with a significant increase in quadriceps 
strength.26 In addition, all of the studies included in this 
review that evaluated physical therapy exercises (including 
open chain exercises with resistance, progressive closed s
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chain quadriceps and hamstring strengthening exercises) in 
patients following ACLR, or artificially created knee effu-
sion, demonstrated significantly improved quadriceps func-
tion (MVIC or CAR), which may indicate restoration of 
more optimal quadriceps neuromuscular function.14
All of the included studies on cryotherapy also demon-
strated significantly improved quadriceps strength,13–16 and 
one study demonstrated reversed decline in motor recruit-
ment (measured by H-reflex),13 in patients with AMI. Cryo-
therapy may reduce the discharge of sensory receptors and 
slow articular nerve conduction, thus decreasing transmis-
sion of the afferent impulses that contribute to deleterious 
spinal reflexive excitability.14
In this review, TENS13 19–21 and NMES17 18 27 had a low level 
quality of evidence to support their efficacy.19 TENS demon-
strated large effect sizes in laboratory trials of artificial knee 
effusions. Although the single clinical trial on ACLR patients 
demonstrated no advantage over cryotherapy or exercise therapy 
alone, treatment with TENS demonstrated effect sizes that 
suggest potential benefits to patients with AMI.21 However, all 
patients in the TENS group also underwent exercise therapy, and 
therefore the role of TENS could not be evaluated in isolation. 
The three clinical trials identified in this study showed small to 
negligible effect sizes.17 18 27 The clinical results for both NMES 
and TENS preclude recommendation of these modalities in the 
management of AMI.
In this scoping review ultrasound therapy24 and vibra-
tion22 23 demonstrated very low-quality evidence for efficacy. 
Although two clinical studies (one vibration and one ultra-
sound) in ACLR patients demonstrated small statistically 
significant improvements (in CAR and H-reflex, respec-
tively), these were of questionable clinical importance. 
Currently these modalities cannot be recommended in the 
management of AMI.
Other therapies including TMS,28 taping,29 30 bracing,31 appli-
cation of heat34 and soft tissue release strategies32 were of no 
clinical benefit in the management of AMI.
limitations
We note that some of the included trials were laboratory 
studies, and these cannot necessarily be extrapolated to the 
clinical scenario of AMI that occurs after ACL injury. The 
study methodology has attempted to account for this when 
Table 2Assessment of Physiotherapy Evidence Database (PEDro) criteria 
study 1 Eligibility
2 
Randomized
3 
Concealed
4 
baseline
5 blinding 
subjects
6 blinding 
therapists
7 blinding 
assessors
8 Outcomes 
>85%
9 Intention to 
treat analysis
10 between group 
comparisons
11 Measures 
of variability score
Hopkins et al13 
2002 1 1 0 1 0 0 0 1 1 1 1 6
Rice et al14 
2009
1 1 0 1 0 0 0 1 1 1 1 6
Hart et al15 
2014
1 1 0 1 0 0 1 1 1 1 1 7
Kuenze et al16 
2017
1 0 0 1 0 0 0 1 1 1 1 5
Lowe and Dong26 
2017
1 0 0 1 0 0 0 1 1 1 1 5
Hart et al21 
2014
1 1 1 1 0 0 0 1 1 1 1 7
Lepley et al17 
2015
1 0 0 1 0 0 0 1 1 1 1 5
Lepley et al18 
2015
1 0 0 1 0 0 0 1 1 1 1 5
Glaviano et al27 
2014
1 1 1 1 1 0 1 1 1 1 1 9
Son et al19 
2016
1 1 1 1 1 0 1 1 1 1 1 9
Konishi et al20 
2017
1 1 0 1 0 0 0 1 1 1 1 6
Pamukoff et al22 
2016
1 1 0 1 0 0 1 1 1 1 1 7
Blackburn et al23 
2014
1 1 0 1 0 0 1 1 1 1 0 6
Norte et al24 
2015
1 1 1 1 1 0 1 1 1 1 1 9
Gibbons et al28 
2010
1 1 0 1 1 0 1 1 1 1 1 8
Kim et al29 
2017
1 1 0 1 1 0 0 1 1 1 1 7
Oliveira et al30 
2016
1 1 0 1 0 0 0 1 1 1 1 6
Davis et al31 
2011
1 1 0 1 0 0 1 0 1 1 1 6
Drover et al32 
2004
1 0 0 0 0 0 0 1 1 0 1 3
Ageberg et al33 
2012
1 1 0 1 1 1 1 1 1 1 1 9
Warner et al34 
2013 1 1 1 1 0 0 1 1 1 1 1 8
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awarding the GRADE level of evidence, with a decrease in 
the score by one level for studies that did not directly assess 
ACL-injured or reconstructed knees. Another limitation was 
that the studies were heterogeneous in design and limited by 
small patient numbers. The quality assessment of the trials 
using the PEDro scale ranged from 3 to 9 out of a maximum 
of 10. Lower quality studies were not excluded due to the 
relatively small number of clinical trials identified. Only 
English-language articles were included.
COnClusIOn
This scoping review demonstrated moderate-quality evidence for 
the efficacy of cryotherapy and physical exercises in improving 
Table 3 GRADE table 
Risk of bias Inconsistency Indirectness Imprecision GRADE score
Cryotherapy Negligible Negligible Serious* Negligible Moderate
Exercise Serious† Negligible Negligible Negligible Moderate
NMES Serious‡ Serious§ Negligible Negligible Low
TENS Negligible Serious§ Serious¶ Negligible Low
Vibration Negligible Negligible Serious** Very serious†† Very low
Ultrasound Negligible Negligible‡‡ Serious§§ Very serious¶¶ Very low
GRADE calculation. 
 Risk of bias: PEDro <6, decrease one grade; PEDro <4, decrease two grades. 
 Inconsistency: Heterogeneity of results (wide variance of effect sizes), decrease one grade. 
 Indirectness: Population of study is not ACLR, decrease one grade. 
 Imprecision: Lower threshold of 95% CI reduces effect to negligible, decrease one grade; lower threshold of 95% CI would alter conclusion or not provided, decrease two grades.
*Indirectness of evidence (only one trial in ACLR patients with AMI).
†PEDro score of 5 for three of the four trials. 
‡PEDro score of 5 for two of the three trials.
§Heterogeneity of results.
¶Indirectness of evidence (effect only seen in laboratory trials). 
**Indirectness of evidence (one of the two trials was a laboratory test).
††Imprecision (CIs or SDs not provided in Blackburn et al23 study). 
‡‡Note: only one study.
§§Indirectness of evidence (knee injury population, not specifically ACL). 
¶¶Imprecision (wide CIs, lower limit of effect size is negative).
ACLR, ACL reconstruction; AMI, arthrogenic muscle inhibition; NMES, neuromuscular electrical stimulation; PEDro, Physiotherapy Evidence Database; TENS, transcutaneous 
electrical nerve stimulation. 
Figure 2 Therapeutic interventions for arthrogenic muscle inhibition and their level of action. NMES, neuromuscular electrical stimulation; TENS, 
transcutaneous electrical nerve stimulation; TMS, transcranial magnetic stimulation.
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quadriceps activation failure after ACL injury and reconstruc-
tion. These therapeutic modalities are therefore recommended 
in the management of AMI.
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